scholarly journals Risk Factor Management in Atrial Fibrillation

2018 ◽  
Vol 7 (2) ◽  
pp. 118 ◽  
Author(s):  
Axel Brandes ◽  
Marcelle D Smit ◽  
Bao Oanh Nguyen ◽  
Michiel Rienstra ◽  
Isabelle C Van Gelder ◽  
...  
Keyword(s):  
Risk Factors ◽  
Atrial Fibrillation ◽  
Clinical Practice ◽  
Management Strategy ◽  
Oral Anticoagulant Therapy ◽  
Rhythm Control ◽  
Current Evidence ◽  
Modifiable Risk Factors ◽  
Early Management ◽  
Risk Factor Management

Atrial fibrillation (AF) is the most common clinical arrhythmia and is associated with increased morbidity and mortality. There is growing evidence that numerous cardiovascular diseases and risk factors are associated with incident AF and that lone AF is rare. Beyond oral anticoagulant therapy, rate and rhythm control, therapy targeting risk factors and underlying conditions is an emerging AF management strategy that warrants better implementation in clinical practice. This review describes current evidence regarding the association between known modifiable risk factors and underlying conditions and the development and progression of AF. It discusses evidence for the early management of underlying conditions to improve AF outcomes. It also provides perspective on the implementation of tailored AF management in daily clinical practice.

scholarly journals Specific Features of the Course of Acute Coronary Syndrome in Patients with Newly Developed Atrial Fibrillation in Clinical Practice According to the Data of the Register of Acute Coronary Syndrome

Kardiologiia ◽  
2019 ◽  
Vol 59 (7) ◽  
pp. 19-25
Author(s):  
Z. G. Tatarintseva ◽  
E. D. Kosmacheva ◽  
S. A. Raff ◽  
S. V. Kruchinova ◽  
V. A. Porkhanov
Keyword(s):  
Risk Factors ◽  
Atrial Fibrillation ◽  
Acute Coronary Syndrome ◽  
Clinical Practice ◽  
Hospital Discharge ◽  
Oral Anticoagulant Therapy ◽  
Inhospital Mortality ◽  
Thromboembolic Complications ◽  
Coronary Syndrome ◽  
Number Of Patients

Aim: to elucidate risk factors of development of atrial fibrillation (AF) in patients with acute coronary syndrome (ACS), and to assess of patient’s adherence to oral anticoagulant therapy (OAT) during 12 months after ACS episode according to the data of the Total ACS Registry for the Krasnodar Territory.Materials and methods. In this retrospective analysis we used Registry data on patients with ACS and concomitant AF, consecutively admitted to cardiological departments of the S.V. Ochapovsky Territorial Clinical Hospital from 20/11/2015 to 20/02/18. Number of patients in the analyzed group was 201 (52 with AF which first appeared in connection with the index ACS). Survivors after hospital discharge were contacted by telephone and at planned visits. The analysis included assessment of rates of the following outcomes: inhospital death, hemorrhagic and thromboembolic complications, prognostic efficacy of the CRISADE and HAS BLED scores, and expediency of prescription to patients with ACS and concomitant first AF episode of prolonged OAT after hospital discharge.Results. Demographic and anamnestic data of patients with the first AF attack at the background of ACS were like those of patients with other types of AF. This group of patients was characterized by more severe course of the disease, but this produced no impact on inhospital mortality and rate of complications, as well as on mortality for 12 months after hospital discharge.Conclusion. The results of this analysis are important for understanding distinctive characteristics of patients with AF first developed during ACS.

scholarly journals Atrial fibrillation and CHA2DS2VASc score of 1 - is there a problem in clinical practice?

2020 ◽  
Vol 25 (3) ◽  
pp. 3738
Author(s):  
E. I. Baranova ◽  
V. A. Pavlova ◽  
V. A. Ionin ◽  
E. Yu. Petrischeva ◽  
O. I. Bliznuk ◽  
...  
Keyword(s):  
Risk Factors ◽  
Atrial Fibrillation ◽  
Clinical Practice ◽  
Anticoagulant Therapy ◽  
Oral Anticoagulant Therapy ◽  
Vascular Diseases ◽  
Nonvalvular Atrial Fibrillation ◽  
Actual Clinical Practice ◽  
Modifying Factors

Aim. To study the incidence of nonvalvular atrial fibrillation (AF) in patients with a CHA2DS2VASc score of 1 in actual clinical practice, to determine the major and minor risk factors of thromboembolism and the frequency of oral anticoagulant therapy in these patients.Material and methods. We performed a retrospective analysis of 6575 medical records of patients hospitalized for five years in a therapeutic inpatient unit. To determine the stroke risk, major and minor modifying factors were assessed.Results. Of 1160 patients with nonvalvular AF, 93 (8,0%) patients had a CHA2DS2VASc score of 1: hypertension (87,1%), heart failure (4,3%), vascular diseases (4,3%), diabetes (2,15%) and age 65-74 years (2,2%); minor modifying factors were as follows: left atrial (LA) dilatation (81,7%), obesity (40,9%), persistent/permanent AF (37,6%), proteinuria (26,9%), chronic kidney disease (3,2%). A combination of minor risk factors was observed in 61,3%, the most common of which were obesity, LA dilatation, persistent/permanent AF. Anticoagulants were prescribed to 72% of patients with a CHA2DS2VASc score of 1.Conclusion. In actual clinical practice, patients with nonvalvular AF with a CHA2DS2VASc score of 1 are often found. The most common risk factors for stroke in these patients are hypertension, persistent or permanent AF, LA dilatation, and obesity. The use of anticoagulant therapy in these patients does not contradict current guidelines. However, further prospective follow-up is necessary to determine the effectiveness and safety of this therapy.

Controlling Hypertension and Stroke Prevention – From Guideline to Clinical Practice

2011 ◽  
Vol 3 (1) ◽  
pp. 30
Author(s):  
Anding Xu ◽  
Zefeng Tan ◽  
◽  
Keyword(s):  
Risk Factors ◽  
Blood Pressure ◽  
Clinical Trials ◽  
Clinical Practice ◽  
Stroke Prevention ◽  
Modifiable Risk Factors ◽  
Cerebrovascular Events

Hypertension is the most important of the prevalent and modifiable risk factors for stroke. Based on evidence, blood pressure (BP) lowering is recommended in guidelines for the prevention of stroke. However, there are still some uncertainties in the guidelines for controlling BP and preventing stroke in patients with previous cerebrovascular events, such as the goal BP, who to treat and which class of BP-lowering drugs to use. This article discusses these questions by reviewing guidelines and corresponding clinical trials, with the aim of reducing the gap between guidelines and clinical practice.

Optimizing Heart Rate and Controlling Symptoms in Atrial Fibrillation

2016 ◽  
Vol 10 (1) ◽  
pp. 26
Author(s):  
Pragnesh Parikh ◽  
◽  
KL Venkatachalam ◽  
Keyword(s):  
Risk Factors ◽  
Atrial Fibrillation ◽  
Rate Control ◽  
Stroke Risk ◽  
Symptom Control ◽  
Review Article ◽  
Rhythm Control ◽  
Ventricular Rate ◽  
Control Methods ◽  
Novel Approaches

Atrial fibrillation (AF) is the most common arrhythmia noted in clinical practice and its incidence and prevalence are on the rise. The single most important intervention is the evaluation and treatment of stroke risk. Once the risk for stroke has been minimized, controlling the ventricular rate and treating symptoms become relevant. In this review article, we emphasize the importance of confirming and treating the appropriate arrhythmia and correlating symptoms with rhythm changes. Furthermore, we evaluate some of the risk factors for AF that independently result in symptoms, underlining the need to treat these risk factors as part of symptom control. We then discuss existing and novel approaches to rate control in AF and briefly cover rhythm control methods.

scholarly journals Atrial thrombi in elective patients considered for atrial fibrillation rhythm control: Risk factors and prognostic value

2021 ◽  
Author(s):  
Marcella Cabral Caires ◽  
Roberto Muniz Ferreira ◽  
Thaís Fonseca Rodrigues ◽  
David Hong Kang ◽  
Lúcia Helena Alvares Salis ◽  
...  
Keyword(s):  
Risk Factors ◽  
Atrial Fibrillation ◽  
Prognostic Value ◽  
Rhythm Control ◽  
Atrial Thrombi ◽  
Elective Patients ◽  
Control Risk

Prevention of atrial fibrillation – non-modifiable and modifiable risk factors for AF

2020 ◽  
Vol 2 (55) ◽  
pp. 14-19
Author(s):  
Agnieszka Wojdyła-Hordyńska ◽  
Grzegorz Hordyński
Keyword(s):  
Risk Factors ◽  
Heart Failure ◽  
Atrial Fibrillation ◽  
Cardiovascular Disease ◽  
Cardiovascular Diseases ◽  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Combined Treatment ◽  
Lifestyle Changes ◽  
Modifiable Risk Factors

Atrial fibrillation is one of the most common arrhythmias, with a significant increase in incidence in recent years. AF is a major cause of stroke, heart failure, sudden cardiac death, and cardiovascular disease. Timely intervention and modification of risk factors increase chance to stop the disease. Aggressive, multilevel prevention tactics are a component of combined treatment, including – in addition to lifestyle changes, anticoagulant therapy, pharmacotherapy and invasive anti-arrhythmic treatment – prevention of cardiovascular diseases, hypertension, ischemia, valvular disease and heart failure.

scholarly journals Rotator cuff disorders: a survey of current (2016) UK physiotherapy practice

2017 ◽  
Vol 10 (1) ◽  
pp. 52-61 ◽  
Author(s):  
Julie Bury ◽  
Chris Littlewood
Keyword(s):  
Clinical Practice ◽  
Rotator Cuff ◽  
Management Strategy ◽  
Online Survey ◽  
Exercise Prescription ◽  
Current Evidence ◽  
Positive Finding ◽  
Cross Sectional ◽  
Initial Management ◽  
Physiotherapy Practice

Background Shoulder pain is a common musculoskeletal presentation, with disorders of the rotator cuff (RC) regarded as the most frequent cause. Conservative treatment is often the initial management; however, findings from a previous survey showed considerable variations in clinical practice, including the use of modalities that are not supported in the literature, suggesting that research is not impacting on practice. The present study aimed to survey current UK physiotherapy practice for the management of RC disorders and to determine whether this has changed over the 5-year period since the last survey was conducted. Methods A cross-sectional online survey of UK physiotherapists was conducted. Results One hundred and ninety-one respondents completed the survey which showed that advice/education and some form of exercise therapy are most commonly used as a management strategy for RC disorders. There is a lack of agreement however regarding exercise prescription. The survey suggests less use of passive modalities, indicating that practice has advanced over the last 5 years in line with the current evidence. Conclusions The present study has highlighted that the clinical practice of the survey respondents was in line with current recommendations from research. Hence, in contrast to the survey conducted 5 years previously, research appears to be impacting on practice, which is a positive finding.

Age Modified Relationship Between Modifiable Risk Factors and the Risk of Atrial Fibrillation

2021 ◽  
Author(s):  
Satoshi Matsuoka ◽  
Hidehiro Kaneko ◽  
Akira Okada ◽  
Kojiro Morita ◽  
Hidetaka Itoh ◽  
...  
Keyword(s):  
Risk Factors ◽  
Atrial Fibrillation ◽  
Modifiable Risk Factors

Interdisciplinary Approach to Cardiovascular Diseases for Research and Everyday Clinical Practice Purposes

2019 ◽  
pp. 139-171
Author(s):  
Aleksander Goch ◽  
Anna Rosiek ◽  
Krzysztof Leksowski ◽  
Emilia Mikołajewska
Keyword(s):  
Risk Factors ◽  
Clinical Practice ◽  
Cardiovascular Diseases ◽  
Interdisciplinary Approach ◽  
Social Awareness ◽  
Modifiable Risk Factors ◽  
Cvd Prevention ◽  
Interdisciplinary Effort ◽  
Professional Resources ◽  
Prevention And Therapy

Cardiovascular Diseases (CVD) are perceived a leading cause of death globally. Scientists and clinicians still search for more efficient prevention, treatment, rehabilitation and care programs suitable for patients with CVD. Common social awareness and interdisciplinary effort may significantly improve current situation, but the problem is more complex. This chapter, based on research and own experiences of authors, tries to answer the question: how maximize professional resources and optimize outcomes in clinical practice. Aim of this chapter is discuss current issues which may potentially influence efficiency of CVD prevention and therapy, including prevention, modifiable and non-modifiable risk factors, ways of cardiac rehabilitation (CR) and cardiac telerehabilitation (CTR), influence of researcher-subject relationship and patient-therapist relationship as far as placebo effect.

Sign in / Sign up

Export Citation Format

Share Document